Browsing by Author/Editor/Contributor Baas, Paul

Jump to a point in the index:
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)TypeCat.
2026Long-term outcomes of preoperative nivolumab with or without relatlimab in patients with resectable non-small-cell lung cancer (NEOpredict-Lung)CUPPENS, Kristof ; Wiesweg, Marcel; Baas, Paul; MAES, Brigitte ; Du Pont, Bert; Ploenes, Till; Theegarten, Dirk; Vanbockrijck, Michel; Aigner, Clemens; Hartemink, Koen; Doerr, Fabian; Bolukbas, Servet; Pat, Karin; Schuler, MartinJournal ContributionA1
2024Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trialSchuler, Martin; CUPPENS, Kristof ; Ploenes, Till; Wiesweg, Marcel; Du Pont, Bert; Hegedus, Balazs; Koester, Johannes; Mairinger, Fabian; Darwiche, Kaid; Paschen, Annette; MAES, Brigitte ; Vanbockrijck, Michel; Laehnemann, David; Zhao, Fang; Hautzel, Hubertus; Theegarten, Dirk; Hartemink, Koen; Reis, Henning; Baas, Paul; Schramm, Alexander; Aigner, ClemensJournal ContributionA1
2024Immune checkpoint inhibition in early-stage non-small cell lung cancerCUPPENS, Kristof ; Du Pont, Bert; Knegjens, Joost; MAES, Brigitte ; Baas, PaulJournal ContributionA1
2023The path forward in early-stage lung cancerCUPPENS, Kristof ; Baas, PaulJournal ContributionA2
2022HLA-I diversity and tumor mutational burden by comprehensive next-generation sequencing as predictive biomarkers for the treatment of non-small cell lung cancer with PD-(L)1 inhibitorsCUPPENS, Kristof ; Baas, Paul; GEERDENS, Ellen ; Cruys, Bert; FROYEN, Guy ; Decoster, Lynn; THOMEER, Michiel ; MAES, Brigitte Journal ContributionA1
Showing results 1 to 5 of 5